News

On 16 July 2026, the FGBI “ARRIAH” in Vladimir hosted a delegation from a Thai company specializing in the import, distribution, and field analysis of biological and veterinary products for animals in Southeast Asia.

During the working visit, FGBI “ARRIAH” specialists presented their developments in the prevention of infectious diseases in livestock and small companion animals to the foreign partners and discussed prospects for further cooperation and opportunities for promoting Russian veterinary products in Southeast Asian markets.

Particular attention was paid to products of potential interest to Southeast Asian countries with developed livestock sectors. Among the developments presented were MastitisVac-EVA, an inactivated vaccine against clinical and subclinical mastitis in cattle caused by major bacterial pathogens, and ARRIAH-Swine-PSH, a combined inactivated emulsion vaccine against pasteurellosis, salmonellosis, and Haemophilus polyserositis in pigs. These products were selected due to their high demand in livestock production: the diseases they are designed to prevent are widespread in many countries, leading to reduced animal productivity and significant economic losses.

In addition, FGBI “ARRIAH” representatives presented other developments for cattle, pigs, and small companion animals.

It was noted during the meeting that the scientific expertise of the FGBI “ARRIAH” enables the development of modern immunobiological products tailored to the epizootic situation in various regions and based on circulating pathogen strains, while the production capacity of the FGBI “ARRIAH” ensures the output of substantial volumes of veterinary products. In the first half of 2026 alone, the FGBI “ARRIAH” produced over 7.4 billion doses of vaccines, of which more than 240 million doses were supplied to foreign markets, including countries in Asia, Africa, the CIS, the EAEU, and the Persian Gulf region.

At the conclusion of the meeting, the parties expressed mutual interest in further developing cooperation, including through additional consultations and the exchange of necessary documentation to continue dialogue on the supply of FGBI “ARRIAH” vaccines for poultry, pigs, cattle, and small ruminants.